Pancreatic tumor-induced gene may prove beneficial as a drug marker

A new mouse model helps scientists better understand the progression of pancreatic cancer and may provide new avenues for the development of therapies, researchers report. Cancer of the pancreas, with a 5% survival rate within five years of diagnosis, is the fourth leading cause of cancer related deaths. The main reason behind such high morbidity is poor early detection capabilities as well as inability of currently employed drugs to alleviate cancer progression.

Read the whole article on Science Daily

More from Science Daily